AHAndreas Hasman

Andreas Hasman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Hasman has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Zero-Dose Children and Nutrition-Service Gaps: A Case for Integrated Delivery in Low- and Middle-Income Countries

    by Kevin Tang, Uchenna Agu, Fanny Sandalinas, Andreas Hasman, Annette Imohe, Ibrahim Dadari

    Background/Objectives: Zero-dose children, defined as those who have not received any routine vaccines, are a central priority of global immunization equity efforts and are widely considered to be among the most deprived children. This study examined whether zero-dose status also identifies children who have not received nutrition services and who are nutritionally vulnerable. Methods: We analyzed data from the Demographic and Health Surveys and Multiple Indicator Cluster Surveys across 55 low- and middle-income countries, including 560,314 children aged 12 to 23 months. We assessed the association between zero-dose status and non-receipt of vitamin A supplementation (VAS) and deworming, and between zero-dose status and the Multidimensional Poverty Index (MPI). Results: Zero-dose status was weakly associated with non-receipt of VAS and deworming (most phi coefficients between 0.1 and 0.3) and with the MPI (mean 0.11), and showed negligible correlation with child nutritional status, measured by stunting and wasting (mean phi 0.03). Most zero-dose children nonetheless had not received these nutrition services, with 62% not receiving VAS and 72% not receiving deworming, amounting to an estimated 12.5 and 14.4 million children, concentrated in a small number of countries. This reflected the generally low coverage of nutrition interventions across all children rather than a specific concentration among the zero-dose. Conclusions: Immunization outreach platforms can therefore be used to extend nutrition services to large numbers of under-reached children.

  • Top Cited Papers
    Open Access

    Exploring the link between women’s empowerment, depression, and anxiety in Bangladesh: evidence from a nationally representative cross-sectional study

    by Yun-Jung Eom, Sion Jang, Andreas Hasman, S V Subramanian, Rockli Kim

    Women's mental health remains critically under-researched in Bangladesh, despite its close links with gender inequality. In this study, we examined how three domains of women's empowerment - attitudes to violence, social independence, and decision-making - are associated with mental health outcomes among currently married women in Bangladesh. Using nationally representative data from the 2022 Bangladesh Demographic and Health Survey, we analysed 18 900 currently married women. We assessed women's empowerment using the survey-based women's empowerment index, which was categorised as low, medium, or high. Depression and anxiety were measured using the Patient Health Questionnaire-9 and the Generalised Anxiety Disorder-7, respectively. We applied multivariable logistic regression models, adjusting for key sociodemographic covariates. Overall, 4.6% women reported depression, and 4.0% reported anxiety. Women with low empowerment in attitude to violence domain had higher odds of depression (adjusted odds ratio (aOR) = 1.48; 95% confidence interval (CI) = 1.17-1.86) and anxiety (aOR = 1.41; 95% CI = 1.09-1.82), compared to women with high empowerment. In the social independence domain, low empowerment was significantly associated with anxiety (aOR = 1.28; 95% CI = 1.02-1.60) but not with depression. Low empowerment in the decision-making domain was not associated with depressive or anxiety symptoms; however, it was associated with lower odds of severe depressive (aOR = 0.48; 95% CI = 0.33-0.70) and anxiety symptoms (aOR = 0.44; 95% CI = 0.28-0.71) when the outcome was disaggregated by severity. Women's empowerment is associated with mental health in Bangladesh. Structural interventions must integrate gender-transformative approaches that challenge discriminatory norms and promote women's social standing, reinforcing the interconnection between Sustainable Development Goal three (good health and well-being) and five (gender equality).


  • Open Access

    Cost-effectiveness analysis of vitamin A supplementation delivery modalities in the DRC, Togo, and Niger: informing sustainable program design

    by Lucia Corball, Kenya Chappel, Hannah Rowett, Arnaud Laillou, Andreas Hasman, Natsuki Kawai

    This study examines how the costs, health impacts, and efficiency of two-dose vitamin A supplementation (VAS) vary across delivery platforms, population subgroups, and delivery contexts in Togo, Niger, and the Democratic Republic of the Congo (DRC). Using a scenario-based model, it compares provider costs and disability-adjusted life years (DALYs) averted and identifies reallocations that maximize health gains under fixed budget constraints. Costs were estimated from the health provider perspective, and health outcomes were measured in DALYs averted. The results showed that cost-effective scenarios varied significantly across countries; in the DRC and Niger, campaigns delivered high coverage but at a substantially higher cost than routine delivery, whereas in Togo, campaigns were both low-cost and high-coverage. In all countries, the most cost-effective scenarios prioritized children aged 6–23 months. More than two-thirds of the cost-effective scenarios achieved better outcomes at lower cost than countries’ current delivery strategies, highlighting significant potential for efficiency gains. A positive, nonlinear relationship between incremental costs and DALYs averted was observed: greater investment generally led to larger health gains but returns diminished as costs increased. A sensitivity analysis showed that facility-based supply shortages negatively affected effectiveness, whereas strengthened routine delivery improved effectiveness. Optimal VAS strategies must be context-specific, balancing the reach of campaigns with the sustainability of routine services. The decision tool provides a practical mechanism for identifying cost-effective delivery strategies tailored to national capacities and constraints.

  • Open Access

    Global assessment of childhood growth monitoring: cross-sectional survey of national policies and practices

    by Annariina Koivu, Ulla Ashorn, Elaine Borghi, Andreas Hasman, Purnima Menon, Aman Pulungan, Julie Ruel-Bergeron, Linda Shaker-Berbari, Madhumita Singh, Naveen Thacker, et al.

    Monitoring children’s growth is a standard practice in paediatric care globally. It is based on the well-established understanding that excessively slow or rapid rates of weight or height gain, which are linked to multiple adverse outcomes, can serve as sensitive indicators of a child’s health. By systematically tracking anthropometric measurements such as weight, height, and […]


  • The political economy of financing traditional vaccines and vitamin A supplements in six African countries

    by Justice Nonvignon, Genevieve Cecilia Aryeetey, Alex Adjagba, Jennifer Asman, Alyssa Sharkey, Andreas Hasman, Sarah W Pallas, Ulla Kou Griffiths

    Vaccines and vitamin A supplementation (VAS) are financed by donors in several countries, indicating that challenges remain with achieving sustainable government financing of these critical health commodities. This qualitative study aimed to explore political economy variables of actors’ interests, roles, power and commitment to ensure government financing of vaccines and VAS. A total of 77 interviews were conducted in Burundi, Comoros, Ethiopia, Madagascar, Malawi and Zimbabwe. Governments and development partners had similar interests. Donor commitment to vaccines and VAS was sometimes dependent on the priorities and political situation of the donor country. Governments’ commitment to financing vaccines was demonstrated through policy measures, such as enactment of immunization laws. Explicit government financial commitment to VAS was absent in all six countries. Some development partners were able to influence governments directly via allocation of health funding while others influenced indirectly through coordination, consolidation and networks. Government power was exercised through multiple systemic and individual processes, including hierarchy, bureaucracy in governance and budgetary process, proactiveness of Ministry of Health officials in engaging with Ministry of Finance, and control over resources. Enablers that were likely to increase government commitment to financing vaccines and VAS included emerging reforms, attention to the voice of citizens and improvements in the domestic economy that in turn increased government revenues. Barriers identified were political instability, health sector inefficiencies, overly complicated bureaucracy, frequent changes of health sector leadership and non-health competing needs. Country governments were aware of their role in financing vaccines, but only a few had made tangible efforts to increase government financing. Discussions on government financing of VAS were absent. Development partners continue to influence government health commodity financing decisions. The political economy environment and contextual factors work together to facilitate or impede domestic financing.


  • Open Access

    Patterns in child stunting by age: A cross‐sectional study of 94 low‐ and middle‐income countries

    by Omar Karlsson, Rockli Kim, Grainne M. Moloney, Andreas Hasman, S. V. Subramanian

    Child stunting prevalence is primarily used as an indicator of impeded physical growth due to undernutrition and infections, which also increases the risk of mortality, morbidity and cognitive problems, particularly when occurring during the 1000 days from conception to age 2 years. This paper estimated the relationship between stunting prevalence and age for children 0–59 months old in 94 low‐ and middle‐income countries. The overall stunting prevalence was 32%. We found higher stunting prevalence among older children until around 28 months of age—presumably from longer exposure times and accumulation of adverse exposures to undernutrition and infections. In most countries, the stunting prevalence was lower for older children after around 28 months—presumably mostly due to further adverse exposures being less detrimental for older children, and catch‐up growth. The age for which stunting prevalence was the highest was fairly consistent across countries. Stunting prevalence and gradient of the rise in stunting prevalence by age varied across world regions, countries, living standards and sex. Poorer countries and households had a higher prevalence at all ages and a sharper positive age gradient before age 2. Boys had higher stunting prevalence but had peak stunting prevalence at lower ages than girls. Stunting prevalence was similar for boys and girls after around age 45 months. These results suggest that programmes to prevent undernutrition and infections should focus on younger children to optimise impact in reducing stunting prevalence. Importantly, however, since some catch‐up growth may be achieved after age 2, screening around this time can be beneficial.


  • Open Access

    Evaluating equity dimensions of infant and child vitamin A supplementation programmes using Demographic and Health Surveys from 49 countries

    by Kevin Tang, Hallie Eilerts, Annette Imohe, Katherine P Adams, Fanny Sandalinas, Grainne Moloney, Edward Joy, Andreas Hasman

    Objectives Vitamin A deficiency affects an estimated 29% of all children under 5 years of age in low/middle-income countries, contributing to child mortality and exacerbating severity of infections. Biannual vitamin A supplementation (VAS) for children aged 6–59 months can be a low-cost intervention to meet vitamin A needs. This study aimed to present a framework for evaluating the equity dimensions of national VAS programmes according to determinants known to affect child nutrition and assist programming by highlighting geographical variation in coverage. Methods We used open-source data from the Demographic and Health Survey for 49 countries to identify differences in VAS coverage between subpopulations characterised by various immediate, underlying and enabling determinants of vitamin A status and geographically. This included recent consumption of vitamin A-rich foods, access to health systems and services, administrative region of the country, place of residence (rural vs urban), socioeconomic position, caregiver educational attainment and caregiver empowerment. Results Children who did not recently consume vitamin A-rich foods and who had poorer access to health systems and services were less likely to receive VAS in most countries despite potentially having a greater vitamin A need. Differences in coverage were also observed when disaggregated by administrative regions (88% of countries) and urban versus rural residence (35% of countries). Differences in vitamin A coverage between subpopulations characterised by other determinants of vitamin A status varied considerably between countries. Conclusion VAS programmes are unable to reach all eligible infants and children, and subpopulation differences in VAS coverage characterised by various determinants of vitamin A status suggest that VAS programmes may not be operating equitably in many countries.


  • Programmatic Implications of a Revised Classification System for Undernutrition

    by Andreas Hasman

    Gausman et al argue that multiple measures of anthropometric failure (AF) are needed to assess undernutrition in the country context and design public health an


  • Open Access

    Consumption of Vitamin-A-Rich Foods and Vitamin A Supplementation for Children under Two Years Old in 51 Low- and Middle-Income Countries

    by Omar Karlsson, Rockli Kim, Andreas Hasman, S. V. Subramanian

    Vitamin A supplementation for children 6–59 months old is an important intervention that boosts immune function, especially where children do not consume enough vitamin-A-rich foods. However, the low coverage of vitamin A supplementation is a persistent problem in low- and middle-income countries. We first estimated the percentage of children 6–23 months old receiving the minimum dietary diversity, vitamin-A-rich foods, and vitamin A supplementation, and second, the difference in the percentage receiving vitamin A supplementation between children 6–23 months old and children 24–59 months old using nationally representative cross-sectional household surveys, namely, the Demographic and Health Surveys, conducted from 2010 to 2019 in 51 low- and middle-income countries. Overall, 22% (95% CI: 22, 23) of children received the minimum dietary diversity, 55% (95% CI: 54, 55) received vitamin-A-rich foods, 59% (95% CI: 58, 59) received vitamin A supplementation, and 78% (95% CI: 78, 79) received either vitamin-A-rich foods or supplementation. A wide variation across countries was observed; for example, the percentage of children that received either vitamin-A-rich foods or supplementation ranged from 53% (95% CI: 49, 57) in Guinea to 96% (95% CI: 95, 97) in Burundi. The coverage of vitamin A supplementation should be improved, especially for children 6–23 months old, in most countries, particularly where the consumption of vitamin-A-rich foods is inadequate.


  • Open Access

    COVID-19 caused significant declines in regular vitamin A supplementation for young children in 2020: what is next?

    by Andreas Hasman, Annette Imohe, Julia Krasevec, Grainne Moloney, Victor M Aguayo